SCHEMBL17811649

SCHEMBL17811649

CCc1cccc(-n2nnn(C)c2=O)c1COc1ccc(-c2ccccc2OC)c(C)n1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNN4 O15554 4/20 0.34
L3MBTL1 Q9Y468 1/20 0.32
HCRTR1 O43613 1/20 0.32
HCRTR2 O43614 1/20 0.32
MAOB P27338 1/20 0.32
DPP4 P27487 1/20 0.32
KDM4E B2RXH2 1/20 0.32
GAA P10253 1/20 0.32
RECQL P46063 1/20 0.32
PDE5A O76074 2/20 0.32
TSHR P16473 1/20 0.32
HTT P42858 1/20 0.32
HSD17B10 Q99714 1/20 0.32
HTR7 P34969 1/20 0.31
TP53 P04637 1/20 0.31
MAPT P10636 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
BRD4 O60885 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17799626 0.93 KCNN4 (0.36) KCNN4L3MBTL1HCRTR1HCRTR2DPP4
SCHEMBL17804245 0.91 SMN1; SMN2 (0.36) KCNN4L3MBTL1HCRTR1HCRTR2DPP4
SCHEMBL17796909 0.87 CD274 (0.35) MAPT
SCHEMBL17804260 0.86 KCNN4 (0.32) KCNN4HCRTR1HCRTR2DPP4PDE5A
SCHEMBL17804249 0.86 KDM5A (0.32) KCNN4DPP4PDE5ATSHRSMN1; SMN2
SCHEMBL17815775 0.86 ADORA3 (0.33) KDM4ETSHRHSD17B10TP53MAPT
SCHEMBL17811650 0.84 ADORA3 (0.31)
SCHEMBL16437306 0.83 KCNN4 (0.39) KCNN4KDM4ERECQLPDE5ATSHR
SCHEMBL16442861 0.83 KCNN4 (0.35) KCNN4L3MBTL1DPP4TSHRHTT
SCHEMBL17811644 0.82 L3MBTL1 (0.31) L3MBTL1KDM4EGAATSHRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9521848-B2 Tetrazolinone compound and use therefor SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-12-20 US disclosed
US-9521848-B2 Tetrazolinone compound and use therefor SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-12-20 US disclosed
US-20160157489-A1 TETRAZOLINONE COMPOUND AND USE THEREFOR SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-06-09 US disclosed
US-20160157489-A1 TETRAZOLINONE COMPOUND AND USE THEREFOR SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160157489-A1 TETRAZOLINONE COMPOUND AND USE THEREFOR CYP51A1, CYP4F11, CYP1B1 KCNN4 1948/4885L3MBTL1 738/4885HCRTR1 307/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.